ArticleCancers2022

Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast Cancer.

Adam L Maddox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.